Pancreatic

Groundbreaking New Blood Test Offers Early Pancreatic Cancer Diagnosis

Researchers applied targeted mass spectrometry to show that pancreatic cancer arises through changes in cellular metabolism.

Pancreatic

Pancreatic Cancer Could be Diagnosed up to Three Years Earlier

Pancreatic cancer could be identified in patients up to three years earlier than current diagnoses, new research suggests.

Pancreatic

Liquid Biopsy Test Detects Pancreatic Cancer Signal

Bluestar Genomics’ liquid biopsy test can detect a pancreatic cancer signal in people across various age groups and in patients with new-onset diabetes.

Sysmex Inostics’ Liquid Biopsy Testing Aids Pancreatic Cancer Management

Sep 9, 2020 | Molecular Diagnostics, Pancreatic

cfDNA-based liquid biopsy analysis of KRAS mutations using OncoBEAM technology can assist in the prognosis determination and management of PDAC patients.

Merus, Caris Life Sciences Collaborate to Detect NRG1 Fusions in Cancer Patients

Jul 23, 2020 | Molecular Diagnostics, Pancreatic, Unknown Origin & Other Cancer Types

Caris will provide DNA and RNA molecular testing to support patient identification and enrollment for Merus’ Zenocutuzumab Phase 1/2 eNRGy trial.

Blood Test May Help Doctors Catch Pancreatic Cancer Early

May 6, 2020 | Cancer, Pancreatic

Penn study shows liquid biopsy may be viable option for both diagnosis and disease staging of pancreatic cancer.

Multicancer Blood Test, Combined with Imaging, Shows Promise as Screen for Cancer

May 4, 2020 | Breast, Cancer, Cervical (HPV), Leukemia, Lung Cancer, Lymphoma, Melanoma, Molecular Diagnostics, Pancreatic, Prostate, Unknown Origin & Other Cancer Types

The blood test followed by PET-CT imaging was 99.6% specific for cancer.

Interventional Study to Evaluate Multicancer Early Detection Test

Apr 21, 2020 | Breast, Cancer, Cervical (HPV), Leukemia, Lung Cancer, Lymphoma, Melanoma, Molecular Diagnostics, Pancreatic, Prostate, Unknown Origin & Other Cancer Types

The Pathfinder study will enroll 6,200 participants to evaluate Grail’s investigational multicancer early detection test in clinical practice.

Cancer Detection and Liquid Biopsy

Apr 13, 2020 | Cancer, Molecular Diagnostics, Pancreatic, Specimen Collection & Handling

Analysis of cell-free DNA in blood samples is revolutionizing cancer treatment and prognosis.

Study Offers Promise for Multicancer Detection from a Single Blood Draw

Apr 6, 2020 | Breast, Cancer, Cervical (HPV), Leukemia, Lung Cancer, Lymphoma, Melanoma, Molecular Diagnostics, Pancreatic, Prostate, Unknown Origin & Other Cancer Types

Bluestar Genomics’ technology can noninvasively detect cancers and help identify the underlying biology of the disease using epigenetic markers.

US Preventive Services Task Force Issues Final Recommendation on BRCA-Related Cancer Prevention

Oct 1, 2019 | Breast, Pancreatic, Prostate

Some women may benefit from risk assessment, counseling, and testing for rare genetic mutations, says USPSTF.

BRACAnalysis CDx Identifies Patients with Metastatic Pancreatic Cancer Who Benefit from Treatment with Lynparza

Sep 24, 2019 | Pancreatic

Updated guidelines from the National Comprehensive Cancer Network recommend genetic testing for all patients with pancreatic cancer.

Biodesix and Immodulon Announce Research Collaboration for Pancreatic Cancer Treatment

Sep 9, 2019 | Cancer, Pancreatic

The partnership will focus on analysis of the circulating proteome of advanced pancreatic cancer patients, using the Biodesix Diagnostic Cortex machine-learning platform.

Researchers Advance Method for Characterizing Pancreatic Cancer

Jul 30, 2019 | Cancer, Molecular Diagnostics, Pancreatic

An Okayama University study reports the utility of identifying PD-L1 status at the time of diagnosing pancreatic cancer and demonstrates that fine-needle aspiration can be useful in facilitating such diagnoses.

BRACAnalysis CDx Test Planned as Companion Diagnostic in Pancreactic Cancer

Mar 8, 2019 | Pancreatic, Research

Early results suggest the test can help expand the population of patients who can benefit from BRCA testing.

Immunovia to Develop Blood-Based Biomarker Tests for Rheumatoid Arthritis

Nov 14, 2018 | Controls, Pancreatic

In a recent study, the company’s IMMray biomarker signatures achieved accuracy greater than 90% when diagnosing CCP-negative rheumatoid arthritis patients compared to healthy controls.